Rosuvastatin has no direct therapeutic effect on myocardial ischemia, but long-term oral administration can inhibit the progression of atherosclerosis, which is beneficial to the treatment of myocardial ischemia. Rosuvastatin is a cholesterol-lowering drug and has the effect of stabilizing plaque, which can be used in the basic treatment of patients with coronary heart disease. Rosuvastatin does not dilate the coronary arteries, can not directly improve myocardial blood supply, mainly by delaying the symptoms of coronary atherosclerosis, play a role in the treatment of coronary heart disease. Rosuvastatin belongs to the western prescription drugs, the adverse effects of the drug are nausea, vomiting, abdominal pain, dizziness, muscle aches and pains, etc. Allergy to the drug components, unexplained elevation of liver enzymes, severe hepatic impairment, lactation and pregnancy women are prohibited. Patients with coronary heart disease should take Rosuvastatin orally under the guidance of a physician, while paying attention to the adverse effects of the drug.